Huawei plans for more AI pharma tie-ups, says healthcare president
Huawei plans to expand its AI partnerships with local pharmaceutical firms for drug development and clinical practices, according to William Zhang, president of Huawei's healthcare unit. This move aims to capitalize on the growing AI drug discovery market, where companies are investing in tools to enhance efficiency. Future collaborations are expected to emerge over the next few years.